TP53 and cancer: Sequencing of 50 cancer-related genes determined that no new mutations were acquired in genes such as EGFR, PIK3CA, KRAS and TP53. Evidence for a switch to increased glycolysis and reduced oxidative phosphorylation in the AQR phenotype was subsequently obtained using several experimental approaches.